Cancer costs and outcomes in the Finnish population 2004–2014

Torkki, Paulus; Leskelä, Riikka‐Leena; Linna, Miika; Mäklin, Suvi; Mecklin∥, Jukka–Pekka; Bono, Petri; Kataja, Vesa; Karjalainen, Sakari

doi:10.1080/0284186x.2017.1343495

Cited by 11 publications

(13 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Overall in Finland, there are almost 33 000 new patients with cancer annually (11) and the number is estimated to increase further. However, the outcomes of cancer care have developed dramatically in recent years and inpatients’ hospital stays have become shorter (5) while outpatient care has increased (12). Therefore, the importance of relatives’ participation in hospital care can be seen not only as an indication of increasing trust in managing at home, but also as an asset and support for the healthcare system (6, 13, 14).…”

Section: Introductionmentioning

confidence: 99%

Cancer patients’ experiences of realization of relatives’ participation in hospital care: a qualitative interview study

Lemetti

Partanen

Hupli

et al. 2020

Scandinavian Caring Sciences

View full text Add to dashboard Cite

Background Relatives’ participation in the care of patients with cancer in hospital is essential to both patients and relatives. Although the meaning of relatives’ participation has been recognized, knowledge about how patients experience this participation is rare. Aims To describe the experiences of patients with cancer of the realization of relatives’ participation in the hospital care. Materials & Methods A qualitative study with semi‐structured interviews of patients with cancer (n=21) were conducted. Data was analyzed using inductive thematic analysis. Results Three main themes were identified among patients’ experiences: Relative as part of the patient’s care, Relative supporting patient’s coping process, and Hospital enabling or preventing relatives’ participation. The relatives were available for patients in seeking information and in the decision‐making process. They helped with the daily needs of the patient, and supported patients emotionally and by managing everyday life at home. The behavior and attitudes of the healthcare professionals and the special nature of the hospital played a central role in the experiences. Conclusion The role of relatives is an important part of the coping process and care of patients with cancer in the hospital.

show abstract

Section: Introductionmentioning

confidence: 99%

Cancer patients’ experiences of realization of relatives’ participation in hospital care: a qualitative interview study

Lemetti

Partanen

Hupli

et al. 2020

Scandinavian Caring Sciences

View full text Add to dashboard Cite

show abstract

“…In an earlier study of cancer cost in Finland by M€ aklin et al in 2006 [8] estimated that 'new expensive treatments' will cause the costs to rise significantly by 2.6-8.5% per year. An earlier study by Torkki et al [12] found that the growth of total costs were only 1.7% per year. This study indicates that one of the major reasons for cancer cost decrease is standardization which occurs in high volume operations.…”

Section: Discussionmentioning

confidence: 93%

“…The cost framework followed the one used in Torkki et al [12]. We evaluated the costs of common cancer sites on a population level, including treatment and indirect costs.…”

Section: Cost Frameworkmentioning

confidence: 99%

“…The data used in the study are from National registries (National Institute for Health and Welfare, National Social Insurance Institution and Cancer Registry). The more detailed description of the data sources and how the cost components were estimated from the data is presented in Torkki et al's study [12].…”

Section: Cost Frameworkmentioning

confidence: 99%

“…There are also some studies that present predictions on the development of cancer costs in the future [6,7]. However, as identified by Tangka et al [9] and Torkki et al [12] the cost components driving cancer costs have developed quite differently in the past. There is a growing trend towards outpatient care, which has decreased inpatient care costs significantly.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014

Torkki

Leskelä²,

Linna

et al. 2018

Acta Oncologica

Self Cite

View full text Add to dashboard Cite

The changes in the cost components indicate that the length of stay has shortened in special care and treatment methods have developed towards outpatient care. This partially explains the decrease of costs. Also, at the same time outcomes improved, which indicates that decrease in costs did not come at the expense of treatment quality. As the survival rates increase, the relevance of mortality measures decreases and the relevance of other, patient-relevant outcome measures increases. In the future, the outcomes and costs of health care systems should be assessed routinely for the most common patient groups.

show abstract

Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis

Wang,

Li,

Lei

et al. 2023

Cancer Medicine

View full text Add to dashboard Cite

BackgroundColorectal cancer (CRC) is one of the most common cancers worldwide. Comprehensive data on the economic burden of CRC at a population‐level is critical in informing policymaking, but such data are currently limited in China.MethodsFrom a societal perspective, the economic burden of CRC in 2019 was estimated, including direct medical and nonmedical expenditure, disability, and premature‐death‐related indirect expenditure. Data on disease burden was taken from the GBD 2019 and analyzed using a prevalence‐based approach. The per‐person direct expenditure and work loss days were from a multicenter study; the premature‐death‐related expenditure was estimated using a human capital approach. Projections were conducted in different simulated scenarios. All expenditure data were in Chinese Yuan (CNY) and discounted to 2019.ResultsIn 2019, the estimated overall economic burden of CRC in China was CNY170.5 billion (0.189% of the local GDP). The direct expenditure was CNY106.4 billion (62.4% of the total economic burden), 91.4% of which was a direct medical expenditure. The indirect expenditure was CNY64.1 billion, of which 63.7% was related to premature death. The predicted burden would reach CNY560.0 billion in 2030 given constant trends for disease burden; however, it would be alternatively reduced to <CNY515.2 billion if the cancer prevention and control goals set by the United Nations and China for 2030 are achieved.ConclusionsThe population‐level economic burden of CRC in China in 2019 seemed noteworthy, with the direct expenditure accounting for more than half. Without effectively reducing exposure to modifiable factors and expanding screening coverage, the burden would continue increasing.

show abstract

Cancer costs and outcomes in the Finnish population 2004–2014

Cited by 11 publications

References 15 publications

Cancer patients’ experiences of realization of relatives’ participation in hospital care: a qualitative interview study

Cancer patients’ experiences of realization of relatives’ participation in hospital care: a qualitative interview study

Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014

Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis

Contact Info

Product

Resources

About